FSTL5 抗体

Gilbertson: "Finding the perfect partner for medulloblastoma prognostication." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 29, Issue 29, pp. 3841-2, (2011) (PubMed).

Remke, Hielscher, Korshunov, Northcott, Bender, Kool, Westermann, Benner, Cin, Ryzhova, Sturm, Witt, Haag, Toedt, Wittmann, Schöttler, von Bueren, von Deimling, Rutkowski, Scheurlen, Kulozik, Taylor et al.: "FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. ..." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 29, Issue 29, pp. 3852-61, (2011) (PubMed).